Jenburkt Pharma launches FDC- Nervijen D3
New Delhi: Known for its popular brand Nervijen, Mumbai-based Jenburkt Pharmaceuticals Limited has recently launched a fixed-dose combination (FDC) of Methylcobalmin & Vitamin-D3 (Cholecalciferol) under the brand name Nervijen D3 tablets in India.
This FDC aims to address the issue of Vitamin D3 and B12 deficiencies, concurrently seen in neuropathy patients due to nutritional deficiency.
The combination of Nervijen D3 consists of Methylcobalamin 1500mcg, Vitamin D3 1000 IU, Alpha Lipoic Acid 100mg, Folic acid 1.5mg, Benfotiamine 7.5mg, Inositol 1.5mg and Biotin 5mcg.
Methylcobalamin, an activated form of Vitamin B12, accelerates myelination, and may help in nerve cell and myelin sheath regeneration. Alpha lipoic acid is a potent antioxidant that helps to reduce oxidative stress and protect peripheral nerves from ischemia. Benfotiamine protects nerves against advanced glycation end products (AGE) formation, improves blood flow to nerves. Folic acid helps in DNA synthesis. Inositol helps in restoring depleted intracellular inositol levels and improves nerve conduction. Biotin boosts nerve function and improves nervous system metabolism. Adding to these constitutes, vitamin D3 increases nerve growth factor (NGF), maintains and improves nerve growth, reduces neuropathic pain, and prevents neuronal degeneration.
Approved by Drug Controller General of India (DCGI), the FDC of Nervijen D3 may help manage symptoms of lower back pain, cervical spondylitis, sciatica, radiculopathy, prolapsed intervertebral disk (PIVD), diabetic peripheral neuropathy, pre-diabetes, metabolic syndrome, cardiovascular disease, alcoholic neuropathy, Vit B12, and Vit D3 deficiency.
"Vitamin D3 and B12 deficiency is a silent epidemic in India with almost 75% percent of the population showing alarming levels of deficiency. It's a known fact that nutritional deficiency has a great influence on nerve repair and worsens neuropathy and it is to address this very need that we have now launched Nervijen D3 tablets the fixed dose combination of Methylcobalamin with Vitamin D3" said Mr Rahul Pimpale, Group Product Manager, Jenburkt Pharmaceuticals Ltd.
"Nervijen D3 will provide a strong therapeutic armamentarium to physicians, neurologists and orthopedicans, in their efforts to protect, repair and restore nerve functions in their patients. The tablets have been launched in small size for better patient compliance." added Mrs Pradnya Pant, Sr Product Manager, Jenburkt Pharmaceuticals Ltd.
Jenburkt Pharmaceuticals Ltd. is a public listed company established in 1985, and is a deeply trusted professionally run company. Jenburkt manufactures pharmaceutical formulations in India and markets them domestically and internationally as well across 13 countries. It is well known for brands like Powergesic and Nervijen.
